Secreted semaphorins could be drug targets for neurodegenerative diseases; for instance, Sema4D antibody was used to rescue cognitive dysfunctions in a mouse model of Huntington disease [37], and depletion of Sema7A has been suggested as a possible treatment for multiple sclerosis [38]. This evidence concerns the gene SEMA7A and Huntington disease.